Blood phosphatidylethanol testing and liver transplant eligibility selection: A step closer

Singal, Ashwani K.; Kwo, Paul Y.

doi:10.1111/acer.14814

Cited by 3 publications

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Of the biomarkers measuring alcohol metabolites, phosphatidylethanol is used most often in clinical practice as it is most accurate, not confounded by endogenous alcohol exposure, and can detect alcohol use within the previous up to 3 weeks from the last drink. 36,37 If an addiction counselor is unavailable, a social worker can fill in this role, which is mainly to assess the biological, psychological, and social assessment of the patient to provide a holistic approach to patient care, and improve patient outcomes. 5 The social worker emphasizes the importance of self-determination and assists patients to develop meaningful goals that support their overall health.…”

Section: Assessment Of Audmentioning

confidence: 99%

See 1 more Smart Citation

Integrated Multidisciplinary Management of Alcohol-Associated Liver Disease

Holbeck,

DeVries,

Singal

2023

J Clin Transl Hepatol

Self Cite

View full text Add to dashboard Cite

Alcohol-associated liver disease (ALD) is one of the most common liver diseases and indications for liver transplantation (LT). Alcohol use disorder (AUD), a frequent accompaniment in ALD patients, may also be associated with psychiatric comorbidities such as depression and anxiety. Identification of ALD at an earlier stage, and treatment of AUD may help prevent progression to advanced stage of ALD such as cirrhosis and alcoholic hepatitis. Screening for alcohol use and AUD treatment in ALD patients is often not performed due to several barriers at the level of patients, clinicians, and administrative levels. This review details the integrated multidisciplinary care model especially on the specific role of the hepatologist, psychiatrist, addiction counselor, and social worker in providing complete management for the dual pathology of liver disease and of AUD. Laboratory assessment, pharmacological and behavioral therapies, and recommended assessments for follow-up care by the respective specialists is outlined. We provide perspective along with the literature support, with the goal of providing team based comprehensive care of patients with ALD.

show abstract

Section: Assessment Of Audmentioning

confidence: 99%

Section: Integrated Multidisciplinary Care Modelmentioning

confidence: 99%